Literature DB >> 21785056

Benign biliary strictures: a current comprehensive clinical and imaging review.

Alampady Krishna Prasad Shanbhogue1, Sree Harsha Tirumani, Srinivasa R Prasad, Najla Fasih, Matthew McInnes.   

Abstract

OBJECTIVE: There is a wide spectrum of nonneoplastic causes of biliary stricture that can pose a significant challenge to clinicians and radiologists. Imaging plays a key role in differentiating benign from malignant strictures, defining the extent, and directing the biopsy. We describe the salient clinical and imaging manifestations of benign biliary strictures that will help radiologists to accurately diagnose these entities.
CONCLUSION: Accurate diagnosis and management are based on correlating imaging findings with epidemiologic, clinical, and laboratory data. Cross-sectional imaging modalities permit precise localization of the site and length of the segment involved, thereby serving as a road map to surgery, and permit exclusion of underlying malignancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785056     DOI: 10.2214/AJR.10.6002

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  11 in total

Review 1.  Benign Biliary Strictures.

Authors:  Ashley Altman; Steven M Zangan
Journal:  Semin Intervent Radiol       Date:  2016-12       Impact factor: 1.513

Review 2.  Biliary Strictures: Etiologies and Medical Management.

Authors:  Terrance Rodrigues; Justin R Boike
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

Review 3.  Percutaneous Management of Benign Biliary Strictures.

Authors:  Adam Fang; Il Kyoon Kim; Ifechi Ukeh; Vahid Etezadi; Hyun S Kim
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

4.  Radiological diagnosis and staging of hilar cholangiocarcinoma.

Authors:  Carlos Valls; Sandra Ruiz; Laura Martinez; David Leiva
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

5.  Role of MRCP in Differentiation of Benign and Malignant Causes of Biliary Obstruction.

Authors:  Meena Suthar; Sunita Purohit; Vivek Bhargav; Pradeep Goyal
Journal:  J Clin Diagn Res       Date:  2015-11-01

Review 6.  Role of fully covered self-expandable metal stent for treatment of benign biliary strictures and bile leaks.

Authors:  Nonthalee Pausawasadi; Tanassanee Soontornmanokul; Rungsun Rerknimitr
Journal:  Korean J Radiol       Date:  2012-04-23       Impact factor: 3.500

7.  Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures.

Authors:  Maria Arechederra; María Rullán; Irene Amat; Daniel Oyon; Lucia Zabalza; Maria Elizalde; M Ujue Latasa; Maria R Mercado; David Ruiz-Clavijo; Cristina Saldaña; Ignacio Fernández-Urién; Juan Carrascosa; Vanesa Jusué; David Guerrero-Setas; Cruz Zazpe; Iranzu González-Borja; Bruno Sangro; Jose M Herranz; Ana Purroy; Isabel Gil; Leonard J Nelson; Juan J Vila; Marcin Krawczyk; Krzysztof Zieniewicz; Waldemar Patkowski; Piotr Milkiewicz; Francisco Javier Cubero; Gorka Alkorta-Aranburu; Maite G Fernandez-Barrena; Jesus M Urman; Carmen Berasain; Matias A Avila
Journal:  Gut       Date:  2021-07-20       Impact factor: 31.793

8.  Diagnosis of Malignant Biliary Strictures: Conventional or Negative Pressure Brush Cytology?

Authors:  Mohammad Reza Abbasi; Seyedeh Masoumeh Ghazi Mirsaeed; Amir Houshang Mohammad Alizadeh
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01

9.  Effects of Paclitaxel-conjugated N-Succinyl-Hydroxyethyl Chitosan Film for Proliferative Cholangitis in Rabbit Biliary Stricture Model.

Authors:  Tao Wang; Hao Zou; Yun-Xia Liu; Xiao-Wen Zhang
Journal:  Chin Med J (Engl)       Date:  2018-03-20       Impact factor: 2.628

Review 10.  Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1.

Authors:  Jean-Marc Dumonceau; Myriam Delhaye; Nicolas Charette; Annarita Farina
Journal:  Therap Adv Gastroenterol       Date:  2020-06-16       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.